1I7G

CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN FROM HUMAN PPAR-ALPHA IN COMPLEX WITH THE AGONIST AZ 242

• PDB DOI: https://doi.org/10.2210/pdb1I7G/pdb

• Classification: TRANSCRIPTION
• Organism(s): Homo sapiens
• Expression System: Escherichia coli
• Mutation(s): No 


• Deposited: 2001-03-09 Released: 2002-03-09 
• Deposition Author(s): Petersen, J.F.W., Cronet, P., Folmer, R., Blomberg, N., Sjoblom, K., Karlsson, U., Lindstedt, E.-L., Bamberg, K.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 2.20 Å
• R-Value Free: 0.271 
• R-Value Work: 0.237 

Literature

Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family.

Cronet, P., Petersen, J.F., Folmer, R., Blomberg, N., Sjoblom, K., Karlsson, U., Lindstedt, E.L., Bamberg, K.

(2001) Structure 9: 699-706

• PubMed: 11587644 
• DOI: https://doi.org/10.1016/s0969-2126(01)00634-7
• Primary Citation of Related Structures:  
  1I7G, 1I7I


• PubMed Abstract: 
  

  The peroxisome proliferator-activated receptors (PPAR) are ligand-activated transcription factors belonging to the nuclear receptor family. The roles of PPARalpha in fatty acid oxidation and PPARgamma in adipocyte differentiation and lipid storage have been characterized extensively. PPARs are activated by fatty acids and eicosanoids and are also targets for antidyslipidemic drugs, but the molecular interactions governing ligand selectivity for specific subtypes are unclear due to the lack of a PPARalpha ligand binding domain structure.

---

Organizational Affiliation: 

Department of Molecular Biology, AstraZeneca R&D Mölndal, S-431 83, Mölndal, Sweden.

Biological Assembly 1  

Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Monomer - A1 

Biological assembly 1 assigned by authors.

Macromolecule Content

• Total Structure Weight: 33.63 kDa 
• Atom Count: 2,188 
• Modelled Residue Count: 259 
• Deposited Residue Count: 287 
• Unique protein chains: 1

Macromolecules

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA	A	287	Homo sapiens	Mutation(s): 0
UniProt & NIH Common Fund Data Resources
Find proteins for Q07869 (Homo sapiens) Explore Q07869  Go to UniProtKB:  Q07869
PHAROS:  Q07869 GTEx:  ENSG00000186951

Small Molecules

Ligands 3 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram
CPQ	D [auth A]	N,N-BIS(3-D-GLUCONAMIDOPROPYL)DEOXYCHOLAMIDE C42 H75 N3 O15 OJSUWTDDXLCUFR-HGZMBBKESA-N
AZ2	C [auth A]	(2S)-2-ETHOXY-3-[4-(2-{4-[(METHYLSULFONYL)OXY]PHENYL}ETHOXY)PHENYL]PROPANOIC ACID C20 H24 O7 S CXGTZJYQWSUFET-IBGZPJMESA-N
NA	B [auth A]	SODIUM ION Na FKNQFGJONOIPTF-UHFFFAOYSA-N

Binding Affinity Annotations
ID	Source	Binding Affinity
AZ2	BindingDB:  1I7G	Ki: 1000 (nM) from 1 assay(s)
		IC50: 3800 (nM) from 1 assay(s)
		EC50: min: 37, max: 9798 (nM) from 10 assay(s)
	PDBBind:  1I7G	IC50: 1000 (nM) from 1 assay(s)
	Binding MOAD:  1I7G	IC50: 1000 (nM) from 1 assay(s)

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 2.20 Å
• R-Value Free: 0.271 
• R-Value Work: 0.237 
• Space Group: P 3₁ 2 1

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 76.968	α = 90
b = 76.968	β = 90
c = 100.592	γ = 120

Software Package:

Software Name	Purpose
EPMR	phasing
CNX	refinement
MOSFLM	data reduction
CCP4	data scaling

Structure Validation

Entry History 

Deposition Data

• Released Date: 2002-03-09 
Deposition Author(s): Petersen, J.F.W., Cronet, P., Folmer, R., Blomberg, N., Sjoblom, K., Karlsson, U., Lindstedt, E.-L., Bamberg, K.

Revision History  

• Version 1.0: 2002-03-09
  Type: Initial release
  
• Version 1.1: 2008-04-27
  Changes: Version format compliance
• Version 1.2: 2011-07-13
  Changes: Version format compliance
• Version 1.3: 2023-08-09
  Changes: Data collection, Database references, Derived calculations, Refinement description